PROGENICS PHARMACEUTICALS INC - PYLARIFY (PIFLUFOLASTAT F-18) FROM PROGENICS PHARMACEUTICALS INC.:1106332 [26-000012]

PIID: 75N90026F00006Solicitation ID: NOI-CC-26-000012

Signed Date: Feb 27, 2026Effective Date: Oct 1, 2025End Date: Closes in 110 days

Award $

$349K

Vendor

PROGENICS PHARMACEUTICALS INC

NAICS

325412

Signed Date

Feb 27, 2026

Key Details

Dollars Obligated

$348,837.12

Base & All Options

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

325412 - PHARMACEUTICAL PREPARATION MANUFACTURING

Product Service Code

6505 - DRUGS AND BIOLOGICALS

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

NORTH BILLERICA, MA, 018622849, CD-MA-03

Description

PYLARIFY (PIFLUFOLASTAT F-18) FROM PROGENICS PHARMACEUTICALS INC.:1106332 [26-000012]

Context & Analysis

On Feb 27, 2026, Department of Health and Human Services obligated $348,837.12 to PROGENICS PHARMACEUTICALS INC for pylarify (piflufolastat f-18) from progenics pharmaceuticals inc.:1106332 [26-000012]. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in NORTH BILLERICA, MA. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining.